Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by valentinemassonon Sep 08, 2020 11:14am
290 Views
Post# 31520148

Good Morning Everyone,

Good Morning Everyone,
The news of RS seems to be causing divisive lines in the proverbial sand. Many here have amassed 10`s of thousands of shares , as have a few big players, albeit in the millions of shares as we have seen in the past months.

 The timing and unpredictability of the RS , many , including myself thought sp should be in the neighbourhood of at least performing the RS to hold $4 US to apply to Nasdaq. The timing is a take charge attitude , according to news releases and interviews ,  Aristotle quite likely has already been presented to clinics , hospital networks , utilizing sz`s new partnerships  pointing to an inroads given by SZ  performing their clients` tests to FDA regulations, stressing the lab to maximum capacity, creating an atmosphere that is robust with activity and a new normal , and accuracy leading up to Aristotle`s release.

 
 The 1/2 penny fluctuation is frustrating and James made it clear he wanted to intervene by performing a reverse split paring down the share count to deter from manipulation. So, it should come as no surprise , the reverse split is occurring much sooner than we expected. After the split, important to remember the entities that have amassed millions of shares and there are a few, may attempt to encourage a sell off to gain more shares from shaky investors . After the split, there will be less than 50 million shares . In comparison, SONA has their own test as SZ does, and has 60 million shares, That went from 1 penny in December 2019 to $16 recently. To those saying SZ will be brought back down to 8 or 9 cents have no interests in the saving of lives with Covid testing and Aristotle . Other interests at play. A market cap of $4 million makes no sense, SZ is projected to have earned upper single digits in USD Millions by EOY, this low cap IMO will not happen. The responsible thing for SZ to do, is exactly whjat they are doing. To those that voted in favor of the split knew the timing could be unpredictable , it certainly has the attention of many. Bravo James.

 All of the above, is in my opinion only and not verbatim. Vets, chime in here .

 Holding ,

 Good luck All.

 VM.
<< Previous
Bullboard Posts
Next >>